Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

South African Treatment Guidelines Need to Consider Viral Load, Not CD4 Count, to Achieve Greater Impact of Treatment as Prevention: Study

March 28, 2014

This article was reported by NAM aidsmap.

NAM aidsmap reported on a study in which the researchers suggest that South Africa should change its recommendation for beginning antiretroviral therapy (ART) to get maximum benefit from treatment as prevention (TasP) by initiating treatment early regardless of CD4 count. In South Africa, guidelines dictate that ART begins with a CD4 count of 350 cells per cubic millimeter (mm3). The researchers contend that data from previous studies, including interim data from the PARTNER study, have shown that HIV-positive individuals with suppressed viral load in serodiscordant

View Full Article


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 
See Also
More on HIV Treatment in South Africa

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement